Published in J Rheumatol on March 01, 2010
Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review. Infect Dis Ther (2013) 0.83
Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients. Rheumatol Int (2015) 0.75
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med (2006) 5.03
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet (2008) 3.00
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial. Ann Rheum Dis (2011) 2.13
Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun (2006) 1.83
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum (2008) 1.73
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.59
Invasive fungal infections in patients with systemic lupus erythematosus. J Rheumatol (2012) 1.44
Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther (2006) 1.42
Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol (2009) 1.25
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum (2010) 1.24
Neuropsychiatric manifestations of systemic lupus erythematosus. J Rheumatol (2013) 1.09
CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol (2011) 1.02
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study. Ann Rheum Dis (2012) 0.96
Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (2012) 0.88
Rheumatoid arthritis and the role of oral bacteria. J Oral Microbiol (2010) 0.87
IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's disease. Reumatol Clin (2013) 0.82
Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol (2013) 0.81
[Recommendations for the medical treatment of rheumatoid arthritis]. Rev Invest Clin (2006) 0.79
A male patient with cavitary pulmonary disease. Reumatol Clin (2012) 0.79
[Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)]. Rev Invest Clin (2009) 0.78
[Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology]. Gac Med Mex (2009) 0.78
[Calciphylaxis, renal failure and gout. A patient with hyperuricemia as a risk factor for death]. Rev Med Inst Mex Seguro Soc (2013) 0.78
Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus. J Clin Immunol (2010) 0.77
Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers. J Pharm Pharmacol (2014) 0.77
Serum cystatin C as a marker of renal function in patients with systemic lupus erythematosus. Reumatol Clin (2012) 0.77
Hyperglycemia and methylprednisolone: comment on the article by den Uyl et al. Arthritis Rheum (2012) 0.76
Concomitant therapy with statins and immunosuppressive agents in childhood primary angiitis of the central nervous system: comment on the article by Cellucci et al. Arthritis Rheum (2012) 0.75
Prevalence of chronic rheumatic diseases in Mexico. J Rheumatol (2011) 0.75
[Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: experience with six pediatric patients. Potential efficacy of methotrexate]. Rev Neurol (2013) 0.75
Estimating glomerular filtration rate. N Engl J Med (2012) 0.75
Severe and unresponsive HIV-associated alopecia areata successfully treated with thalidomide. Acta Derm Venereol (2005) 0.75
Renal function assessment in patients with systemic lupus erythematosus. Rheumatol Int (2011) 0.75
Economic impact of estimating renal function in patients with systemic lupus erythematosus. Nefrologia (2012) 0.75
CKD-EPI is the most reliable equation to estimate renal function in patients with systemic lupus erythematosus. Nefrologia (2013) 0.75
Laboratory biomarkers for guiding therapy with methotrexate in rheumatoid arthritis. Curr Pharm Des (2015) 0.75
Lupus nephritis: advances in the knowledge of its immunopathogenesis without the expected therapeutic success? Reumatol Clin (2013) 0.75
Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman. Rheumatology (Oxford) (2012) 0.75
Neuropsychiatric manifestations in systemic lupus erythematosus: physiopathogenic and therapeutic basis. Reumatol Clin (2013) 0.75
Medical ethics, research and the pharmaceutical industry. Reumatol Clin (2012) 0.75